Home   >  
Angiogenesis/Protein Tyrosine Kinase
  • Jak/Stat Pathway
∨
  >  
EGFR

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

EGFR

Chemical Structure Cat. No. Product Name CAS No.
Mobocertinib succinate Chemical Structure
 BCP33315 Mobocertinib succinate 2389149-74-8
Mobocertinib succinate is a potent and orally active inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, with selectivity over WT EGFR. Antitumor activity.
Norcantharidin Chemical Structure
 BCP25426 Norcantharidin 29745-04-8
Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.
ONO7475 Chemical Structure
 BCP33232 ONO7475 1646839-59-9
ONO-7475 is a potent and orally active Axl/Mer inhibitor. ONO-7475 targets and binds to both Axl and Mer, and prevents their activity.
Tyrphostin AG30 Chemical Structure
 BCP32895 Tyrphostin AG30 122520-79-0
Tyrphostin AG30 is an antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.
JBJ-04-125-02 Chemical Structure
 BCP32863 JBJ-04-125-02 2060610-53-7
JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFRL858R/T790M.
EGFR inhibitor Chemical Structure
 BCP32602 EGFR inhibitor 879127-07-8
EGFR inhibitor is an EGFR inhibitor. It directly depolymerizes microtubules and is used as a chemical probe to investigate both the EGFR pathway and microtubule dynamics.
Tarloxotinib bromide Chemical Structure
 BCP32560 Tarloxotinib bromide 1636180-98-7
Tarloxotinib bromide is an irreversible EGFR/HER2 inhibitor.
Butein Chemical Structure
 BCP31369 Butein 21849-70-7
Butein is a chalcone that is (E)-chalcone bearing four additional hydroxy substituents at positions 2', 3, 4 and 4'.
BI-4020 Chemical Structure
 BCP31931 BI-4020 BI4020
BI-4020 is a fourth-generation, orally active, and non-covalent EGFR tyrosine kinase inhibitor. BI-4020 inhibits not only the triple mutant EGFR del19 T790M C797S variant (IC50=0.2 nM in BaF3 cell lines) but also the double mutant EGFR del19 T790M and primary mutant EGFR del19 (IC50=1 nM). BI-4020 also shows activity against EGFR wt (IC50=190 nM). BI-4020 shows high kinome selectivity and good DMPK properties.
JBJ-04-125-02 Chemical Structure
 BCP31914 JBJ-04-125-02 2140807-05-0
JBJ-04-125-02 is a single agent can inhibit cell proliferation and EGFRL858R/T790M/C797S signaling in vitro and in vivo.
123下一页末页共 122 条记录 1 / 13 页 
0086-13720134139